跳至主要内容
临床试验/CTRI/2024/08/071971
CTRI/2024/08/071971尚未招募Unknown

Comparison of efficacy, safety and cost effectiveness of montelukast plus bilastine versus montelukast plus levocetirizine in patients of allergic rhinitis: prospective , randomised, open label parallel study - Nil

Dr Ganesh Dakhale0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients suffering from non-specific allergic rhinitis of either gender, in age group 18 to 65 years.
  • 2. History of intermittent or persistent allergic rhinitis of any severity with no obvious cause prior to inclusion in study.
  • 3. Patients with TNSS greater than 8 not treated with anti-histamines in last 7 days.

排除标准

  • 1. History of asthma requiring chronic use of inhaled corticosteroids.
  • 2. Had been unresponsive to anti-histamine in the past.
  • 3. History of allergy to the study medication or unable to tolerate anti-histamines.
  • 4. Use of study drug in last 1 week prior to baseline.
  • 5. Pregnant and nursing women.
  • 6. Subjects with history of significant haematopoietic, hepatic, renal, cardiovascular, neurological, psychiatric or autoimmune disease.

研究者

发起方
Dr Ganesh Dakhale

相似试验

Effectiveness of montelukast plus bilastine vs... | 临床试验